You are here » Home » Companies » Company Overview » Transgene Biotek Ltd

Transgene Biotek Ltd.

BSE: 526139 Sector: Health care
NSE: N.A. ISIN Code: INE773D01018
BSE 00:00 | 08 Aug 3.30 0.07
(2.17%)
OPEN

3.38

HIGH

3.38

LOW

3.17

NSE 05:30 | 01 Jan Transgene Biotek Ltd
OPEN 3.38
PREVIOUS CLOSE 3.23
VOLUME 17458
52-Week high 4.88
52-Week low 3.02
P/E
Mkt Cap.(Rs cr) 25
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00
OPEN 3.38
CLOSE 3.23
VOLUME 17458
52-Week high 4.88
52-Week low 3.02
P/E
Mkt Cap.(Rs cr) 25
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00

Transgene Biotek Ltd. (TRANSGENEBIOTEK) - Company History

Transgene Biotek was incorporated as a private limited company in Mar.'90 and was converted into a public limited company in Nov.'90.The company is engaged in the research and development and manufacture of various medical reagents both chemical and immuno-diagnostic reagents for the qualitative and quantitative estimation of bio-chemical parameters and diagnosis of diseases respectively.Transgene Biotek's products are exported to Africa Russia China Malaysia and the Phillipines. The company chalked out a new project for setting up a manufacturing facility at a cost of Rs.30 crore at the Anrich Industrial AreaBollaram. TBL is working of four new plants:Oral deliver of proteins and peptides:DNA vaccines:fusion proteins and bio therapeutics. The new project is being funded by way of preferential offer to Batterymarch Financial management USA and other financial institutions.

.